new Omicron variant, Novavax says it’s developing COVID-19 vaccine | Omivacron Kovid variant: Novavax says vaccine is being developed

Washington The company says it is trying to develop a vaccine against the new Kovid variant.

The company said it was trying to develop a spike protein against the new vaccine. Indonesia and the Philippines last week approved the immediate use of the Novavox vaccine. The vaccine is expected to be approved in the US by the end of the year.

According to reports, the European Medical Agency and Canada may approve the vaccine.

.